Influence of the nature of pre-contraction on the responses to commonly employed vasodilator agents in rat-isolated aortic rings

Fundamental and Clinical Pharmacology

Volumn 16, Issue 6, 2002, Pages 485-494

  Streefkerk, Jörn O ^a   De Groot, Annemieke A ^a   Pfaffendorf, Martin ^a   Van Zwieten, Pieter A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aorta; Contraction; Endothelium; Vascular; Vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 (2 CHLORO 5 TRIFLUOROMETHYLPHENYLIMINO)IMIDAZOLIDINE; ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL L TYPE; FORSKOLIN; METHACHOLINE; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM ION; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; ENDOTHELIUM; ISOLATED ARTERY; MEMBRANE DEPOLARIZATION; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; IN VITRO STUDY; MUSCLE CONTRACTION; MUSCLE RELAXATION; PHYSIOLOGY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0036454756     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2002.00107.x     Document Type: Article

References (26)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 288 373-376.
2. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. (1989) 65 1-21.
3. Angus J.A., Wright C.E., Xi Q. Targeting voltage-gated calcium channels in cardiovascular therapy. Lancet (2000) 356 1287-1289.
4. Berridge M.J. Capacitative calcium entry. Biochem. J. (1995) 312 (Part 1) 1-11.
5. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature (1993) 361 315-325.
6. Berridge M.J. Elementary and global aspects of calcium signalling. J. Physiol. (1997) 499 (Part 2) 291-306.
7. Lew M.J. Extended concentration-response curves used to reflect full agonist efficacies and receptor occupancy-response coupling ranges. Br. J. Pharmacol. (1995) 115 745-752.
8. ++ utilization in the constriction of rat aorta to full and partial alpha-1 adrenoceptor agonists. J. Pharmacol. Exp. Ther. (1986) 238 224-231.
9. Tabernero A., Giraldo J., Vila E. Effect of NG-nitro-L-arginine methylester (L-NAME) on functional and biochemical alpha 1-adrenoceptor-mediated responses in rat blood vessels. Br. J. Pharmacol. (1996) 117 757-763.
10. Bevan J.A., Bevan R.D., Shreeve S.M. Variable receptor affinity hypothesis. FASEB J. (1989) 3 1696-1704.
11. Oriowo M.A., Bevan J.A., Bevan R.D. Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve. J. Pharmacol. Exp. Ther. (1989) 251 16-20.
12. Nishimura K., Ota M., Ito K. Existence of two components in the tonic contraction of rat aorta mediated by alpha 1-adrenoceptor activation. Br. J. Pharmacol. (1991) 102 215-221.
13. Korstanje C., Wilffert B., De Jonge A., Thoolen M.J., Timmermans P.B., Van Zwieten P.A. Calcium influx-dependent and -independent alpha 1-adrenoceptor-mediated processes of vasoconstriction in vivo do not operate via different alpha 1-adrenoceptor subtypes. J. Cardiovasc. Pharmacol. (1984) 6 1102-1108.
14. Dorn G.W., Becker M.W. Thromboxane A2 stimulated signal transduction in vascular smooth muscle. J. Pharmacol. Exp. Ther. (1993) 265 447-456.
15. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991) 43 109-142.
16. i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium (1994) 15 122-131.
17. Lucas K.A., Pitari G.M., Kazerounian S. et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. (2000) 52 375-414.
18. Hampl V., Huang J.M., Weir E.K., Archer S.L. Activation of the cGMP-dependent protein kinase mimics the stimulatory effect of nitric oxide and cGMP on calcium-gated potassium channels. Physiol. Res. (1995) 44 39-44.
19. Rembold C.M., Chen X.L. Mechanisms responsible for forskolin-induced relaxation of rat tail artery. Hypertension (1998) 31 872-877.
20. Hirata T., Ushikubi F., Kakizuka A., Okuma M., Narumiya S. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J. Clin. Invest. (1996) 97 949-956.
21. Cracowski J.L., Stanke-Labesque F., Chavanon O. et al. Thromboxane A(2) modulates cyclic AMP relaxation and production in human internal mammary artery. Eur. J. Pharmacol. (2000) 387 295-302.
22. Eckly-Michel A., Martin V., Lugnier C. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br. J. Pharmacol. (1997) 122 158-164.
23. - channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J. (1994) 13 1065-1072.
24. Plane F., Wiley K.E., Jeremy J.Y., Cohen R.A., Garland C.J. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery. Br. J. Pharmacol. (1998) 123 1351-1358.
25. Bang L., Nielsen-Kudsk J.E., Gruhn N. et al. Vascular smooth muscle contraction is an independent regulator of endothelial nitric oxide production. Scand. Cardiovasc. J. (1999) 33 71-78.
26. Dora K.A., Martin P.E., Chaytor A.T., Evans W.H., Garland C.J., Griffith T.M. Role of heterocellular gap junctional communication in endothelium-dependent smooth muscle hyperpolarization: Inhibition by a connexin-mimetic peptide. Biochem. Biophys. Res. Commun. (1999) 254 27-31.